769
An 18-year-old Japanese man weighing 53 kg with an anaplastic large cell lymphoma received continuous IV administration of TAC as post-transplantation prophylaxis against graft-versus-host disease (GVHD) after an allogeneic bone marrow transplantation (BMT).
 An 18-year-old Japanese man weighing 53 kg with an anaplastic large cell lymphoma: Subject; Japanese: Subject.Race; 18-year-old: Subject.Age; man: Subject.Gender; graft-versus-host disease (GVHD): Effect; received continuous IV administration of TAC: Treatment; allogeneic bone marrow transplantation (BMT): Treatment; cell lymphoma: Treatment.Disorder; TAC: Treatment.Drug; IV administration: Treatment.Route
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 An 18-year-old Japanese man weighing 53 kg with an anaplastic large cell lymphoma: Subject; Japanese: Subject.Race; 18-year-old: Subject.Age; man: Subject.Gender; graft-versus-host disease (GVHD): Effect; received continuous IV administration of TAC: Treatment; allogeneic bone marrow transplantation (BMT): Treatment; cell lymphoma: Treatment.Disorder; TAC: Treatment.Drug; IV administration: Treatment.Route